Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Solventum today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation.

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Solventum today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation.

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Solventum today reported financial results for the fourth quarter ended December 31, 2024.

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Solventum will host an investor day on Thursday, March 20, 2025, beginning at approximately 1:00 p.m. Eastern Standard Time. The event will be held in New York City and simultaneously webcast online.

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

Solventum today announced it has entered into a definitive agreement to sell its Purification & Filtration1 business to Thermo Fisher Scientific Inc. for $4.1 billion. Solventum expects the transaction to be neutral to 2025 EPS and expects an estimated $3.4 billion in net proceeds, which it intends to use primarily to pay down debt. The transaction is expected to be completed by the end of 2025, subject to regulatory approval and customary closing conditions.

Solventum Fluency for Imaging clinches top spot again: Ranked #1 Best in KLAS for Speech Recognition: Front-end Imaging

Solventum today announced that its AI-powered radiology speech reporting solution, Solventum™ Fluency™ for Imaging has ranked #1 in the 2025 Best in KLAS Awards—Software and Services Report(opens in a new tab) for the fifth time.

Solventum to Participate in the Piper Sandler Healthcare Conference

Solventum announced today that its executives will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024 at 11:30 a.m. ET in New York, NY.

Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance

Solventum today reported financial results for the third quarter ended September 30, 2024.

Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Solventum will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close. The company will also host a conference call that day at 4:30 p.m. Eastern Time to discuss its third quarter financial results and provide an update on its business.